Orisantin (Dipyridamole, Acetylsalicylic Acid)

Dipyridamole, the active ingredient in Orisantin, is an antiplatelet agent presented as a oral tablet for cardiovascular use. It is used to inhibit platelet aggregation and improve blood flow in patients at risk of thrombotic events.

GNH USA supplies Orisantin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orisantin combines dip‑re‑d with acetyl‑sali­cyl­ic acid to target the platelet activation pathway of the cardiovascular system and offers the following clinical applications: - Secondary prevention of ischemic stroke or transient TIA : reduces the risk of  re‑  re  re . -   -  . -  - . - .

...